Skip to content

Magnetic Anchoring Guided Endoscopic Submucosal Dissection for Early Gastric Caner

Prospective Clinical Trial of Magnetic Anchoring Guided Endoscopic Submucosal Dissection for Early Gastric Caner

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04327050
Acronym
MAGESD
Enrollment
30
Registered
2020-03-30
Start date
2020-05-01
Completion date
2021-04-30
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

magnetic anchored guidance, early gastric cancer, endoscopic submucosal dissection

Brief summary

This study uses magnetic anchored guidance system to treat early gastric cancer by endoscopic mucosal dissection to test the advantages of magnetically anchored guidance system for surgical field exposure during endoscopic mucosal dissection.

Detailed description

Gastric cancer is the second most common malignant tumor in China, with the highest mortality rate among all types of malignant tumors. Surgical resection is still the most effective treatment for gastric cancer. Minimally invasive surgery breaks the traditional surgical concept that the laparotomy must be performed by laparotomy. It can complete the operation that required a large incision with minimal incision trauma, and has the advantages of less trauma, faster recovery and fewer complications. At present, the application of gastroscopy and laparoscopy for early gastric cancer has reached consensus at home and abroad. Endoscopic mucosal resection of early gastric cancer is suitable for patients with intramucosal cancer and no lymph node metastasis. However, the unclear exposure of the surgical field during the operation causes difficulty in operation or conversion to open surgery is a difficult problem facing this technique. The project designed a magnetic pulling unit that can be connected through an endoscope, including external abdominal magnets, internal abdominal magnets, connecting hooks, and micro surgical tweezers. Using magnetic anchoring technology, the magnetic pulling unit is anchored to the abdominal wall, and micro surgical tweezers are used. The tumor tissue is pulled indirectly, so that the mucosa is lifted up, which is beneficial to the peeling of the submucosa. This method increases the operating space of the main hand of the endoscope, and at the same time, the magnetic clamp is used to connect the clamps so that they can move in all directions, so as to achieve the desired traction of the tumor tissue site, fully expose the surgical field, and facilitate surgical anatomy.

Interventions

PROCEDUREMagnetic anchored guided endoscopic submucosal dissection

Using magnetic anchoring technology, the magnetic pulling unit is anchored to the abdominal wall, and micro surgical tweezers are used. The tumor tissue is pulled indirectly, so that the mucosa is lifted up, which is beneficial to the peeling of the submucosa.

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

No masking required

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients are diagnosed as of gastric cancer by a preliminary endoscopy or biopsy sampling

Exclusion criteria

* Patients with a cardiac pacemaker or severe cardiac and/or pulmonary diseases * Patients without informed consent * Patients with other malignant tumors

Design outcomes

Primary

MeasureTime frameDescription
success ratethrough study completion, an average of 1 yearThe rate of the complete resection of gastric lesion by magnetic anchored guided endoscopic submucosal dissection

Secondary

MeasureTime frameDescription
complicationsmeasured at the time of the end of each ESD; up to 1 hourthe complications in magnetic anchored guided endoscopic submucosal dissection

Contacts

Primary ContactXiaogang Zhang, MD
47608867@qq.com0086-028-85323900

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026